CellBion Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cellbion.co.kr
Pipeline Analysis Reveals 85+ Drugs in Development for Metastatic Prostate Cancer Treatment
• DelveInsight's comprehensive analysis identifies over 80 pharmaceutical companies actively developing 85+ pipeline drugs for metastatic prostate cancer treatment.
• Novel therapies in development include TAVT-45, a reformulated abiraterone acetate, and Onvansertib, a first-in-class PLK1 inhibitor, demonstrating innovation in treatment approaches.
• Multiple clinical trials are underway, including Phase III studies by major players like Bayer, AstraZeneca, and Novartis, evaluating new treatment combinations and targeted therapies.
© Copyright 2025. All Rights Reserved by MedPath